期刊文献+

总疗程时间对Lewis肺癌治疗效应影响的实验研究 被引量:3

The experimental study of effect of overall treatment tune on Lewis lung carcinoma
原文传递
导出
摘要 目的探讨放射总疗程对Lewis肺癌治疗效果的影响。材料与方法将荷瘤C57小鼠随机分入2,4,6,8天4个不同总疗程组中,每组取5个剂量点,分隔剂量为6~15Gy,总照射剂量为24~60Gy。Lewis肺癌的治疗效应用TCD_(50)(50%肿瘤控制所需的外放射剂量)作为观察指标。结果随着疗程缩短,生存曲线左移,TCD_(50)值下降。疗程2~8天,TCD_(50)值分别为48.71Gy,38.45Gy,34.82Gy,28.60Gy,TCD_(50)值与疗程天数呈显著线性相关(P<0.05)。结论在总疗程时间为2~8天的范围内,缩短总疗程时间提高了Lewis肺癌的治疗效果。 Purpose To study the effect of shorting overall treatment time on Lewis lung carcinoma. Materials and Methods TCD 50,defined as the total dose in controlling 50 % tumor,was used to measure the curative effects of Lewis lung carcinoma .The TCD50 assays were performed in four different overall treament schedules(2,4,6,8 days).The total dose of 24Gy~60Gy was given in 4 fractions with fractionated dose ranging from 6 Gy to 15 Gy,Resdults The survival curves moved left and the TCD 50 values decreased as the overall treatment time shorting from 8 days to 2 days.The value of TCD 50 was 48.71Gy, 38.45Gy,34.82Gy,28.60Gy for overall treatment time 8.6,4,2 days, respectively,There was line regression between TCD50 and overall treatment time. Conclusion The improvement of tumor curative effects was obtained as overall treatment time shorting from 8 days to 2 days.
出处 《中华放射肿瘤学杂志》 CSCD 1996年第4期255-258,共4页 Chinese Journal of Radiation Oncology
基金 "肺癌国家八五攻关课题"资助
关键词 LEWIS肺癌 总疗程 TCD<sub>50</sub> Overall treatment time TCD 50 Lewis lung carcinoma
  • 相关文献

同被引文献84

  • 1傅深,蒋国梁,王丽娟,钱浩,叶明,傅晓龙,赵森,何少琴,刘泰福.超分割放疗非小细胞肺癌疗效分析──临床Ⅲ期研究[J].中华肿瘤杂志,1994,16(4):306-309. 被引量:18
  • 2冯培芳,刘鲁明,沈玉英.参麦注射液对晚期癌症患者sIL-2R、LAK及NK细胞活性影响[J].中国中西医结合杂志,1995,15(2):87-89. 被引量:89
  • 3Dresler CM.Appropriate diagnostic evaluation.Curr Probl Cancer,1996,20(3):147.
  • 4Saunders MI.Predictive testing of radiosensitivity of non-small cell carcinoma of the lung.Lung Cancer,1994,10(Suppl):S83.
  • 5Mcdonald S,Rubin P,Phillips TL,et al.Injury to the lung from cancer therapy:Clinical syndromes,measurable endpoint.and potential scoring system.Int J Radial Oncol Biol Phys,1995,31(5):1187.
  • 6Herrmenn T,Schorcht J,Molls M(Eds).Radiation Pneurnopathy in "Late Sequelar in Oncology".Dunst J and Sauer R.Springer-Verlag,1992.135-140.
  • 7Dosoretz DE,Katin MJ.Blitzer PH,et al.Medically inoperable lung cancer:The role of radiation therapy.Sctrinar Radiat Oncol,1996,6(2):98.
  • 8Ganden S,Rarnsay J,Tripcony L.The curative treatment by radiotherapy alone of stage I non-small cell lung cancer.Chest,1995,108(5):1278.
  • 9Cox JD,Azamia N,Byhardt RW,et al.A randomized phase I/Ⅱ trial of hyperfractionated radiation therapy with total dose of 60.0Gy to 79.2Gy:Poesible benefit with 69.6Gy in favorable patients with Radiation Therapy Oncology Group atage Ⅲ non-small cell lung cancer:Report of RTOG 83.11.J Clin Oncol,1990,8(9):1543.
  • 10蒋国榛 王丽娟 傅深 等.超分割放闻非小细胞肝癌临床I/Ⅱ期试验[J].中华放谢肿瘤学杂志,1993,2(4):231-231.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部